Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04707885 · ClinicalTrials.gov registry record · NA
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
A NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 5
- Study locations
NCT04707885: Recruiting NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by Ohio State University.
NCT04707885 is a NA study of Hearing Loss and Hearing Loss, Sensorineural that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 40 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04707885, a NA study of Hearing Loss and Hearing Loss, Sensorineural, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 5
- Study locations
Study Summary
The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).
Primary Outcome
Determine the hearing preservation advantage, by measuring low tone audiometry at the 3, 6,12 and 24 month timepoints, in hertz.
Conditions Studied
Interventions
- DEVICE Electrocochleography
Study Locations (5)
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University in St. Louis - St Louis
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Ohio
- Ohio State University Eye and Ear Institute - Columbus
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT04707885 shows while recruiting
NCT04707885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Electrocochleography is the first listed.
NCT04707885 lists 5 locations in 5 states (Minnesota, Missouri, North Carolina).
Frequently Asked Questions
What is clinical trial NCT04707885 about?
NCT04707885 is a clinical study titled "Clinical Utility of Residual Hearing in the Cochlear Implant Ear". The current study is a randomized multi-center clinical trial that investigates the role an intraoperative hearing monitoring system (electrocochleography) has on helping to save residual hearing in patients undergoing cochlear implantation (CI).
What is the current status of trial NCT04707885?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-11-10. Estimated completion is 2027-12-31.
What conditions does trial NCT04707885 study?
This clinical trial studies the following conditions: Hearing Loss, Hearing Loss, Sensorineural, Hearing Loss, Bilateral.
What interventions are being tested in trial NCT04707885?
The interventions under investigation include: Electrocochleography (DEVICE).
Who is sponsoring clinical trial NCT04707885?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04707885 being conducted?
This trial has 5 study locations across Minnesota, Missouri, North Carolina, Ohio, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04707885's enrollment target sits among peer trials
40 45th of 58 higher than 12 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI